iSpecimen (ISPC) EBITDA Margin Growth (3y) (2023 - 2026)
iSpecimen (ISPC) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | -168.00 |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 360.00 |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | -56.00 |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | -247.00 |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 4,378.00 |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 2,862.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 146.00 |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 20.00 |
| 10 | iSpecimen | 692,995.30 | -2.13 Mn | 71,599.00 | -154,091.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -154,091.00 |
| Dec 31, 2025 | -512,056.00 |
| Sep 30, 2025 | -253,515.00 |
| Jun 30, 2025 | -14,488.00 |
| Mar 31, 2025 | -6,129.00 |
| Dec 31, 2024 | -31,756.00 |
| Sep 30, 2024 | -1,039.00 |
| Jun 30, 2024 | -2,355.00 |
| Mar 31, 2024 | -9,922.00 |
| Dec 31, 2023 | -7,711.00 |
| Sep 30, 2023 | -4,685.00 |
| Jun 30, 2023 | -19,890.00 |